title: [Value of positron emission tomography in urological neoplasms: more form than substance?].
abstract: Positron emission tomography/computed tomography (PET/CT) is widely used for imaging urological neoplasms. This overview should help the urologist actively involved in oncology to assess the value of PET or PET/CT in each tumor entity. Besides prostate, testicular, renal, and bladder cancer less common urological malignancies like penile carcinoma and retroperitoneal masses are discussed. Differences in using PET/CT for primary diagnosis, staging, or restaging are outlined separately. Appropriate indications for the use in clinical practice are cited.
authors.affiliation: Klinik für Urologie, Universitätsklinikum Ulm, Prittwitzstraße 43, 89075 Ulm, Deutschland.
authors.forename: J
authors.initials: J
authors.lastname: Müller
authors.forename: M
authors.initials: M
authors.lastname: Schrader
authors.forename: A J
authors.initials: AJ
authors.lastname: Schrader
authors.forename: M
authors.initials: M
authors.lastname: Höpfner
authors.forename: F
authors.initials: F
authors.lastname: Zengerling
mesh_terms: D018450:Disease Progression; D006801:Humans; D007089:Image Enhancement; D007090:Image Interpretation, Computer-Assisted; D008207:Lymphatic Metastasis / Q000473:pathology; D064847:Multimodal Imaging; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000473:pathology; D009367:Neoplasm Staging; D018365:Neoplasm, Residual / Q000175:diagnosis / Q000473:pathology; D049268:Positron-Emission Tomography; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed; D014571:Urologic Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery